{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:38:07Z","timestamp":1776940687972,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-025-11136-3","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T09:54:54Z","timestamp":1740477294000},"page":"6279-6291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of effective synthetic molecules against viral-induced cytokine release syndrome using in silico and in vitro approaches"],"prefix":"10.1007","volume":"29","author":[{"given":"Hira Noor","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almas","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajda","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana\u2019a","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaheer","family":"Ul-Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"2","key":"11136_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cr.7310019","volume":"16","author":"RB Seth","year":"2006","unstructured":"Seth RB, Sun L, Chen ZJ (2006) Antiviral innate immunity pathways. Cell Res 16(2):141\u2013147. https:\/\/doi.org\/10.1038\/sj.cr.7310019","journal-title":"Cell Res"},{"issue":"12","key":"11136_CR2","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3390\/jcm9124021","volume":"9","author":"V Lariccia","year":"2020","unstructured":"Lariccia V et al (2020) Challenges and opportunities from targeting inflammatory responses to SARS-CoV-2 infection: a narrative review. J Clin Med 9(12):4021. https:\/\/doi.org\/10.3390\/jcm9124021","journal-title":"J Clin Med"},{"issue":"1","key":"11136_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-020-00131-w","volume":"40","author":"R Otsuka","year":"2020","unstructured":"Otsuka R, Seino K-I (2020) Macrophage activation syndrome and COVID-19. Inflamm Regen 40(1):1\u20136. https:\/\/doi.org\/10.1186\/s41232-020-00131-w","journal-title":"Inflamm Regen"},{"key":"11136_CR4","doi-asserted-by":"publisher","unstructured":"Malik HN et al (2022) Benzophenone and coumarin derivatives as 3-CLPro inhibitors: Targeting cytokine storm through in silico and in vitro approaches. J\u00a0Mol\u00a0Struct,  133478. https:\/\/doi.org\/10.1016\/j.molstruc.2022.133478","DOI":"10.1016\/j.molstruc.2022.133478"},{"key":"11136_CR5","doi-asserted-by":"publisher","unstructured":"Bassetti M, Vena A, Giacobbe DR (2020) The novel Chinese coronavirus (2019\u2010nCoV) infections: challenges for fighting the storm. Eur\u00a0J\u00a0Clin Invest 50(3). https:\/\/doi.org\/10.1111\/eci.13209","DOI":"10.1111\/eci.13209"},{"issue":"9","key":"11136_CR6","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200160","volume":"10","author":"A Fara","year":"2020","unstructured":"Fara A et al (2020) Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol 10(9):200160. https:\/\/doi.org\/10.1098\/rsob.200160","journal-title":"Open Biol"},{"key":"11136_CR7","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9456","volume":"111","author":"B Liu","year":"2020","unstructured":"Liu B et al (2020) Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun 111:102452. https:\/\/doi.org\/10.3892\/etm.2020.9456","journal-title":"J Autoimmun"},{"key":"11136_CR8","doi-asserted-by":"publisher","unstructured":"Bonaventura A  et al (2020) Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies. Front\u00a0Immunol, p. 1625. https:\/\/doi.org\/10.3389\/fimmu.2020.01625","DOI":"10.3389\/fimmu.2020.01625"},{"issue":"6","key":"11136_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1021\/acsbiomedchemau.2c00039","volume":"2","author":"AM Rabie","year":"2022","unstructured":"Rabie AM, Abdalla M (2022) Forodesine and Riboprine exhibit strong anti-SARS-CoV-2 repurposing potential: in silico and in vitro studies. ACS Bio  Med Chem Au 2(6):565\u2013585. https:\/\/doi.org\/10.1021\/acsbiomedchemau.2c00039","journal-title":"ACS Bio Med Chem Au"},{"key":"11136_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102845","volume":"66","author":"DB Mahmoud","year":"2021","unstructured":"Mahmoud DB et al (2021) Delineating a potent antiviral activity of Cuphea gnea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies. J Drug Deliv Sci Technol 66:102845. https:\/\/doi.org\/10.1016\/j.jddst.2021.102845","journal-title":"J Drug Deliv Sci Technol"},{"key":"11136_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106947","volume":"88","author":"L Heimfarth","year":"2020","unstructured":"Heimfarth L et al (2020) Drug repurposing and cytokine management in response to COVID-19: a review. Int Immunopharmacol 88:p106947. https:\/\/doi.org\/10.1016\/j.intimp.2020.106947","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"11136_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L et al (2020) COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther 5(1):1\u20138","journal-title":"Signal Transduct Target Ther"},{"key":"11136_CR13","doi-asserted-by":"crossref","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17(5\u20136):490\u2013519","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P"},{"issue":"7811","key":"11136_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582(7811):289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"issue":"1","key":"11136_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/14756366.2020.1737045","volume":"35","author":"M Ali","year":"2020","unstructured":"Ali M et al (2020) Synthesis and characterisation of thiobarbituric acid enamine derivatives, and evaluation of their \u03b1-glucosidase inhibitory and anti-glycation activity. J Enzyme Inhib Med Chem 35(1):692\u2013701. https:\/\/doi.org\/10.1080\/14756366.2020.1737045","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"11","key":"11136_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241739","volume":"15","author":"WH Roshdy","year":"2020","unstructured":"Roshdy WH et al (2020) EGYVIR: an immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS ONE 15(11):e0241739. https:\/\/doi.org\/10.1371\/journal.pone.0241739","journal-title":"PLoS ONE"},{"issue":"4","key":"11136_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/aac.18.4.536","volume":"18","author":"F Hayden","year":"1980","unstructured":"Hayden F, Douglas R Jr, Simons R (1980) Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother 18(4):536\u2013541. https:\/\/doi.org\/10.1128\/aac.18.4.536","journal-title":"Antimicrob Agents Chemother"},{"key":"11136_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123540","volume":"234","author":"AM Khan","year":"2023","unstructured":"Khan AM et al (2023) Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays. Int J Biol Macromol 234:123540. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123540","journal-title":"Int J Biol Macromol"},{"key":"11136_CR19","doi-asserted-by":"publisher","unstructured":"Cho J et al. (2020) Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep 10(1):16200. https:\/\/doi.org\/10.1038\/s41598-020-72879-7","DOI":"10.1038\/s41598-020-72879-7"},{"issue":"2","key":"11136_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1084\/jem.156.2.492","volume":"156","author":"SL Helfand","year":"1982","unstructured":"Helfand SL, Werkmeister J, Roder JC (1982) Chemiluminescence response of human natural killer cells. .I The relationship between target cell binding, chemiluminescence, and cytolysis. J Exp Med 156(2):492\u2013505. https:\/\/doi.org\/10.1084\/jem.156.2.492","journal-title":"J Exp Med"},{"issue":"4","key":"11136_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.niox.2005.06.003","volume":"13","author":"MA Andrade","year":"2005","unstructured":"Andrade MA et al (2005) Increased rat alveolar macrophage expression of functional iNOS induced by a Dirofilaria immitis immunoglobulin superfamily protein. Nitric Oxide 13(4):217\u2013225. https:\/\/doi.org\/10.1016\/j.niox.2005.06.003","journal-title":"Nitric Oxide"},{"issue":"12","key":"11136_CR22","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1373\/clinchem.2005.051532","volume":"51","author":"RM Lequin","year":"2005","unstructured":"Lequin RM (2005) Enzyme immunoassay (EIA)\/enzyme-linked immunosorbent assay (ELISA). Clin Chem 51(12):2415\u20132418. https:\/\/doi.org\/10.1373\/clinchem.2005.051532","journal-title":"Clin Chem"},{"key":"11136_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104313","volume":"104","author":"S Javed","year":"2020","unstructured":"Javed S et al (2020) Fungal mediated biotransformation of melengestrol acetate, and T-cell proliferation inhibitory activity of biotransformed compounds. Bioorg Chem 104:104313. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104313","journal-title":"Bioorg Chem"},{"key":"11136_CR24","doi-asserted-by":"publisher","unstructured":"Plumb JA (2004) Cell sensitivity assays: the MTT assay. Cancer Cell Culture, pp 165\u2013169. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_20","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"11136_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11626-998-0130-x","volume":"34","author":"SL Voytik-Harbin","year":"1998","unstructured":"Voytik-Harbin SL et al (1998) Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Biol Anim 34:239\u2013246. https:\/\/doi.org\/10.1007\/s11626-998-0130-x","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"11136_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay MA et al (2019) Acute respiratory distress syndrome. Nat Rev Dis Primers 5(1):18. https:\/\/doi.org\/10.1038\/s41572-019-0069-0","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"11136_CR27","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1056\/nejm200005043421806","volume":"122","author":"MA Matthay","year":"2012","unstructured":"Matthay MA, Ware LB, Zimmerman GA (2012) The acute respiratory distress syndrome. J Clin Investig 122(8):2731\u20132740. https:\/\/doi.org\/10.1056\/nejm200005043421806","journal-title":"J Clin Investig"},{"issue":"5","key":"11136_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","volume":"52","author":"T Hirano","year":"2020","unstructured":"Hirano T, Murakami M (2020) COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(5):731\u2013733. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.003","journal-title":"Immunity"},{"key":"11136_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100719","volume":"53","author":"S Dro\u017cd\u017cal","year":"2020","unstructured":"Dro\u017cd\u017cal S et al (2020) FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat 53:100719. https:\/\/doi.org\/10.1016\/j.drup.2020.100719","journal-title":"Drug Resist Updat"},{"issue":"1","key":"11136_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250\u2013256. https:\/\/doi.org\/10.1002\/jmv.26232","journal-title":"J Med Virol"},{"issue":"3","key":"11136_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/hcr.0000000000000027","volume":"34","author":"M Janic","year":"2014","unstructured":"Janic M et al (2014) A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males. J Cardioplum Rehabil 34(3):208\u2013212. https:\/\/doi.org\/10.1097\/hcr.0000000000000027","journal-title":"J Cardioplum Rehabil"},{"key":"11136_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105820","volume":"172","author":"D Zhang","year":"2021","unstructured":"Zhang D et al (2021) Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacol Res 172:105820. https:\/\/doi.org\/10.1016\/j.phrs.2021.105820","journal-title":"Pharmacol Res"},{"issue":"11","key":"11136_CR33","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1046\/j.1365-2222.2003.01701.x","volume":"33","author":"M Nori","year":"2003","unstructured":"Nori M et al (2003) Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines. Clin Exp Allergy 33(11):1544\u20131554. https:\/\/doi.org\/10.1046\/j.1365-2222.2003.01701.x","journal-title":"Clin Exp Allergy"},{"key":"11136_CR34","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3389\/fimmu.2020.02094","volume":"11","author":"G Palma","year":"2020","unstructured":"Palma G et al (2020) PI3K\u03b4 inhibition as a potential therapeutic target in COVID-19. Front Immunol 11:2094. https:\/\/doi.org\/10.3389\/fimmu.2020.02094","journal-title":"Front Immunol"},{"issue":"1","key":"11136_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108959","volume":"35","author":"M Dittmar","year":"2021","unstructured":"Dittmar M et al (2021) Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-CoV-2. Cell Rep 35(1):108959. https:\/\/doi.org\/10.1016\/j.celrep.2021.108959","journal-title":"Cell Rep"},{"issue":"6","key":"11136_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2230.2008.02843.x","volume":"33","author":"Y Zhao","year":"2008","unstructured":"Zhao Y et al (2008) Carebastine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor. Clin Exp Dermatol 33(6):785\u2013787. https:\/\/doi.org\/10.1111\/j.1365-2230.2008.02843.x","journal-title":"Clin Exp Dermatol"},{"key":"11136_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.reprotox.2020.05.009","volume":"95","author":"JB Suleiman","year":"2020","unstructured":"Suleiman JB et al (2020) Obesity-induced testicular oxidative stress, inflammation and apoptosis: protective and therapeutic effects of orlistat. Reprod Toxicol 95:113\u2013122. https:\/\/doi.org\/10.1016\/j.reprotox.2020.05.009","journal-title":"Reprod Toxicol"},{"issue":"7","key":"11136_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.chembiol.2019.04.002","volume":"26","author":"M Shin","year":"2019","unstructured":"Shin M et al (2019) Diacylglycerol lipase-\u03b2 is required for TNF-\u03b1 response but not CD8+ T cell priming capacity of dendritic cells. Cell Chem Biol 26(7):1036-1041.e3. https:\/\/doi.org\/10.1016\/j.chembiol.2019.04.002","journal-title":"Cell Chem Biol"},{"issue":"8","key":"11136_CR39","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/cells10082060","volume":"10","author":"B-R Jin","year":"2021","unstructured":"Jin B-R et al (2021) Anti-obesity drug orlistat alleviates Western-Diet-Driven colitis-associated colon cancer via inhibition of STAT3 and NF-\u03baB-mediated signaling. Cells 10(8):2060. https:\/\/doi.org\/10.3390\/cells10082060","journal-title":"Cells"},{"key":"11136_CR40","doi-asserted-by":"publisher","unstructured":"Kovalchuk A et al (2021) Fighting the storm: could novel anti-TNF\u03b1 and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19? Aging (Albany NY) 13(2):1571. https:\/\/doi.org\/10.18632\/aging.202500","DOI":"10.18632\/aging.202500"},{"key":"11136_CR41","doi-asserted-by":"publisher","unstructured":"Tsai-Nguyen G, Modrykamien AM (2018)  Use of neuromuscular blocking agents in acute respiratory distress syndrome. in Proc (Bayl Univ Med Cent). Taylor & Francis Milton Park. https:\/\/doi.org\/10.1080\/08998280.2017.1416237","DOI":"10.1080\/08998280.2017.1416237"},{"issue":"12","key":"11136_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.amjmed.2004.10.018","volume":"117","author":"PJ Barnes","year":"2004","unstructured":"Barnes PJ (2004) The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med Suppl 117(12):24\u201332. https:\/\/doi.org\/10.1016\/j.amjmed.2004.10.018","journal-title":"Am J Med Suppl"},{"key":"11136_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","volume":"68","author":"J An","year":"2017","unstructured":"An J et al (2017) Antimalarial drugs as immune modulators: new mechanisms for old drugs. Annu Rev Med 68:317\u2013330. https:\/\/doi.org\/10.1146\/annurev-med-043015-123453","journal-title":"Annu Rev Med"},{"issue":"5","key":"11136_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/dom.14648","volume":"24","author":"L Ojeda-Fern\u00e1ndez","year":"2022","unstructured":"Ojeda-Fern\u00e1ndez L et al (2022) Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: a population-based study in Lombardy. Diabetes Obes Metab 24(5):891\u2013898. https:\/\/doi.org\/10.1111\/dom.14648","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"11136_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s42000-019-00101-z","volume":"18","author":"Y-C Lin","year":"2019","unstructured":"Lin Y-C et al (2019) The effects of acarbose on chemokine and cytokine production in human monocytic THP-1 cells. Hormones 18(2):179\u2013187. https:\/\/doi.org\/10.1007\/s42000-019-00101-z","journal-title":"Hormones"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11136-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11136-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11136-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:29:06Z","timestamp":1763728146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11136-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11136"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11136-3","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}